CDC releases new guidance about 9-valent HPV vaccine
KEY POINT
CDC released additional guidance on use of 9-valent human papillomavirus (HPV) vaccine (Gardasil 9—Merck), which focused on general vaccine information, series completion with this newer vaccine, and use in patients who previously completed the three-dose HPV vaccination series with the quadrivalent or bivalent HPV vaccines.
SOURCES
Centers for Disease Control and Prevention. Announcement: additional guidance online for providers regarding 9-Valent HPV vaccine use among persons who previously received HPV Vaccination.. Accessed September 5, 2015.
